S.Africa’s Dis-Chem profit jumps as drugs demand rebounds

Reuters

– South Africa’s Dis-Chem Pharmacies Ltd reported a 35.3% jump in half-year earnings on Wednesday, helped by pent-up demand for medicines and vaccines after the easing of pandemic lockdowns.

Business confidence in South Africa has returned to pre-pandemic levels, as retailers see increased demand and footfall thanks to COVID-19 vaccination drives, easing restrictions and stimulus measures. Dis-Chem’s revenue surged 19.2% over the past two months.

Dis-Chem, which runs the second-largest chain of pharmacies in South Africa and competes with Clicks Group, said it had administered 405,000 COVID-19 vaccine doses during the half-year ended August, with that number increasing to 860,000 by the end of October.

However, a disproportionate rise in sales of lower-margin products related to COVID-19 during and after the second and third pandemic waves left transactional gross margin behind sales growth year-on-year, the company said.


The company’s headline earnings per share, a key metric of profit for South African companies, came in at 48.7 cents for the half-year ended August, the drug store chain said. Revenue rose 16.6% to 14.9 billion rand ($967.49 million).


($1 = 15.4007 rand)

(Reporting by Muhammed Husain and Pushkala Aripaka in Bengaluru; Editing by Ramakrishnan M.)

tagreuters.com2021binary_LYNXMPEHA209C-BASEIMAGE

You appear to be using an ad blocker

Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.